Cart
sales@molnova.com
GW 405833
CAS No. 180002-83-9
GW 405833( L-768242 )
Catalog No. M20934 CAS No. 180002-83-9
GW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 72 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 200 | Get Quote |
|
| 50MG | 312 | Get Quote |
|
| 100MG | 464 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGW 405833
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective.
-
DescriptionGW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective.
-
In Vitro——
-
In Vivo——
-
SynonymsL-768242
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180002-83-9
-
Formula Weight447.35
-
Molecular FormulaC23H24Cl2N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (279.42 mM)
-
SMILESCOc1ccc2c(c1)c(CCN1CCOCC1)c(C)n2C(=O)c1cccc(Cl)c1Cl
-
Chemical Name1-(23-Dichlorobenzoyl)-5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li A L Carey L M Mackie K et al. The cannabinoid CB 2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB 1 mechanism that is independent of CB 2 receptors in mice[J]. Journal of Pharmacology and Experimental Therapeutics 2017 362(2):jpet.117.241901.
molnova catalog
related products
-
Tetrahydromagnolol
Tetrahydromagnolol can activate cannabinoid (CB) receptors.
-
VCE-004.3
VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator.
-
Cannabichromene
Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).
